Evidence map›Paper›PMID 25951122›Full record

ReviewChest2015

Optimizing atrial fibrillation management: from ICU and beyond.

Allan J Walkey, D Kyle Hogarth, Gregory Y H Lip

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Chest, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04092621 (Rapid Atrial Fibrillation Treatment Strategy), which is not on this map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04092621 phase4unknown statusnot on this mapstarted 2019, after this paper: background citation

Rapid Atrial Fibrillation Treatment Strategy

TypeinterventionalSponsorOur Lady of the Lake HospitalRan2019 to 2020Enrolled40ConditionsNew Onset Atrial Fibrillation, Sepsis, Respiratory FailureArmsAmiodarone in Parenteral Dosage Form, Amiodarone Pill, Direct Current Cardioversion (DCC), Rate-control therapy
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Initial Precipitants and Recurrence of Atrial Fibrillation.Circulation. Arrhythmia and electrophysiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Allan J WalkeyDivision of Pulmonary and Critical Care Medicine, The Pulmonary Center, Boston University School of Medicine, Boston, MA. Electronic address: alwalkey@bu.edu.
D Kyle HogarthSection of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago Medicine, Chicago, IL.
Gregory Y H LipCentre for Cardiovascular Sciences, University of Birmingham, Birmingham, England; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Boston University · USUniversity of Birmingham · GBUniversity of Chicago · US

Funding

Atrial Fibrillation in Sepsis: Patient Outcomes and Provider Practice PatternsK01HL116768 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WALKEY, ALLAN J. · 2013 to 2017
$742k
NHLBI NIH HHS K01 HL116768NHLBI NIH HHS K01HL116768
6 · The paper itself

Abstract

Atrial fibrillation (AF) that newly occurs during critical illness presents challenges for both short- and long-term management. During critical illness, patients with new-onset AF are clinically evaluated for hemodynamic instability owing to the arrhythmia as well as for potentially reversible arrhythmia triggers. Hemodynamically significant AF that persists during critical illness may be treated with heart rate or rhythm control strategies. Recent evidence suggests that patients in whom AF develops during acute illness (eg, sepsis, postoperatively) have high long-term risks for AF recurrence and for AF-associated complications, such as stroke, heart failure, and death. Therefore, we suggest increased efforts to improve communication of AF events between inpatient and outpatient providers and to reassess patients who had experienced new-onset AF during critical illness after they transition to the post-ICU setting. We describe various strategies for the assessment and long-term management of patients with new-onset AF during critical illness.

Indexed as

Disease ManagementIntensive Care UnitsAtrial FibrillationCardiac Resynchronization TherapyHumans

Identifiers

PMID25951122
PMCPMC4594627
OpenAlexW2170892838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.